[HTML][HTML] Cancer immunotherapy based on natural killer cells: current progress and new opportunities

W Hu, G Wang, D Huang, M Sui, Y Xu - Frontiers in immunology, 2019 - frontiersin.org
Cancer immunotherapy has been firmly established as a new milestone for cancer therapy,
with the development of multiple immune cells as therapeutic tools. Natural killer (NK) cells …

NKG2D and its ligands in cancer

P Dhar, JD Wu - Current opinion in immunology, 2018 - Elsevier
Highlights•NKG2D pathway is significant for both innate and adoptive tumor
immunity.•Soluble and membrane-bound NKG2D ligands confer opposite role in tumor …

Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment

T Courau, J Bonnereau, J Chicoteau, H Bottois… - … for immunotherapy of …, 2019 - Springer
Background Immunotherapies still fail to benefit colorectal cancer (CRC) patients. Relevant
functional assays aimed at studying these failures and the efficacy of cancer immunotherapy …

[HTML][HTML] Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

E Mamessier, A Sylvain, ML Thibult… - The Journal of …, 2011 - Am Soc Clin Investig
NK cells are a major component of the antitumor immune response and are involved in
controlling tumor progression and metastases in animal models. Here, we show that …

p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells

A Iannello, TW Thompson, M Ardolino… - Journal of Experimental …, 2013 - rupress.org
The induction of cellular senescence is an important mechanism by which p53 suppresses
tumorigenesis. Using a mouse model of liver carcinoma, where cellular senescence is …

[HTML][HTML] Human gut-associated natural killer cells in health and disease

A Poggi, R Benelli, R Venè, D Costa, N Ferrari… - Frontiers in …, 2019 - frontiersin.org
It is well established that natural killer (NK) cells are involved in both innate and adaptive
immunity. Indeed, they can recognize molecules induced at the cell surface by stress signals …

[HTML][HTML] Leveraging NKG2D ligands in immuno-oncology

MB Fuertes, CI Domaica, NW Zwirner - Frontiers in Immunology, 2021 - frontiersin.org
Immune checkpoint inhibitors (ICI) revolutionized the field of immuno-oncology and opened
new avenues towards the development of novel assets to achieve durable immune control …

NKG2D ligands as therapeutic targets

P Spear, MR Wu, ML Sentman, CL Sentman - Cancer immunity, 2013 - AACR
Abstract The Natural Killer Group 2D (NKG2D) receptor plays an important role in protecting
the host from infections and cancer. By recognizing ligands induced on infected or tumor …

Inherent and tumor-driven immune tolerance in the prostate microenvironment impairs natural killer cell antitumor activity

C Pasero, G Gravis, M Guerin, S Granjeaud… - Cancer research, 2016 - AACR
The field of immunotherapy for solid tumors, such as prostate cancer, has been recently
focusing on therapies that can counter tumor-mediated immunosuppression. Precise …

NK cells in the tumor microenvironment

C Guillerey - Tumor Microenvironment: Hematopoietic Cells–Part B, 2020 - Springer
Natural killer cells are powerful effectors of innate immunity that constitute a first line of
defense against cancer. NK cells express an array of germline-encoded receptors which …